Traws Pharma, Inc. — Director's Dealing 2022

Aug 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2022-08-02

Reporting Person: Gelder Mark S. MD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-02	Common Stock	M	4650	—	Acquired	7031	Direct
2022-08-03	Common Stock	F	1135	$1.32	Disposed	5896	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-02	Restricted Stock Units	$	M	4650	Disposed		Common Stock (4650)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.